The FDA approved Orbactiv (oritavancin), an intravenous antibacterial for adults with acute bacterial skin and skin structure infections caused by certain susceptible bacteria, including MRSA. It is the third such drug cleared this year, after Dalvance and Sivextro.
Section archive
Page 36 of 288
Health News
Drugs, disease, healthcare, government and lifestyle: health news beyond the plate.
- All desks
- Abortion
- Accutane
- Acetaminophen
- Acid Reflux
- Acidic Foods
- Acne
- Acrylamide
- Acupuncture
- Additives
- ADHD
- Adiposity
- Advisories
- Aerobic Exercise
- Aflatoxin
- Agave
- Agent Orange
- Aging
- Agriculture
- AIDS
- Air Pollution
- Airline Passengers
- Airport
- ALA
- Alcohol
- Alcoholic Beverage
- Alerts
- Allergy
- Alli
- Aloe Vera
- ALS
- Alternative Medicine
- Aluminum
- Alzheimer's
- Amalgam
- AMD
- Ampyra
- Amygdala
- Anal Cancer
- And
- Anemia
- Angiogenesis
- Animal Protein
- Animals
- Anorexia
- Anthocyanins
- Anthrax
- Anti-Angiogenesis
- Anti-Obesity
- Antibacterial
- Antibiotic
Miscellaneous
VIZIO Recalls to Repair 39- and 42-Inch E-Series Flat Panel Televisions
VIZIO is recalling about 245,000 39- and 42-inch E-Series flat panel televisions because the stand assembly can fail and let the set tip over, posing an impact injury risk. VIZIO has received 51 reports; owners should contact the company for a repair.
Government
Mom, Can I Get Contact Lenses, Please?
FDA optometrist Bernard Lepri weighs contact lenses for children: they resist breakage in sports and can sharpen vision in very nearsighted kids, and one Ohio State study found better self-perception. He stresses they are medical devices needing supervision and responsible use.
Miscellaneous
Release: Feature Documentary ROOTED in PEACE Debuts at AREDAY for Aspen Premiere, Aug. 11
Sundance alumnus Greg Reitman premieres his documentary ROOTED in PEACE on August 11 at the American Renewable Energy Summit in Aspen, screening for Jimmy Carter, Ted Turner and Sylvia Earle, with a Q&A and the launch of his One Tree Movement.
Miscellaneous
FearLess Revolution Meets At the Epicenter: Merger Combines Online Resources, Live Events to Help Educate Green Business Leaders and Consumers
Alex and Ana Bogusky's FearLess Revolution and the Boulder speaker series At the Epicenter have joined the Living GREEN Foundation in a nonprofit project offering content, videos and live events for green businesses, healthy lifestyle entrepreneurs and consumer advocates.
Miscellaneous
Year-round preventive treatment reduces malaria risk in young children
An NIH-funded study in Uganda found monthly preventive drug treatment from 6 to 24 months of age substantially cut young children's malaria risk with no serious adverse events. Earlier trials had mostly tested short courses in places with only a seasonal risk.
Drug
Statin use boosts diabetes mellitus risk
A cohort study of more than 2 million UK patients found statin users had a 57 percent higher rate of type 2 diabetes, with longer use linked to greater risk. The authors stress this was not a trial and cannot show statins caused the added risk.
Miscellaneous
Media Registration open for APEC HR Development Ministerial Meeting
Media registration is open until August 19 for the APEC Human Resource Development Ministerial Meeting in Ha Noi on September 6, where ministers will address youth employability, labor mobility, skills development and pension reform.
Miscellaneous
Expression Injectable by Enhancement Medical: FDA Safety Communication - Adverse Events Associated with Unapproved Use As a Dermal Filler
The FDA says it has received reports of swelling, lumps, bruising and hard nodules tied to using Expression, a hyaluronic acid product listed only as an intranasal splint, as a dermal filler. It advises providers to stop and use approved fillers instead.
Miscellaneous
Adverse Events Associated with Use of Enhancement Medical's "Expression" Intranasal Splint as a Dermal Filler
FDA has received reports of adverse events after Enhancement Medical's Expression, a hyaluronic acid product listed as an intranasal splint, was injected as a dermal filler. It is not approved for that use, and FDA tells providers to stop injecting it under the skin.
Miscellaneous
Bar Stool, Dive Computers Recalled
CPSC announced two recalls: about 350 Scubapro Aladin2 dive computers in the US that can leak and stop working, risking decompression sickness, and a bar stool sold at Costco by Samson International that poses a fall hazard.
Miscellaneous
Filling in Wrinkles Safely
FDA-approved injectable dermal fillers smooth wrinkles and plump lips and cheeks, with most achieving an effect that lasts about six months or longer, and people generally report satisfaction. FDA medical officer Janette Alexander says patients should learn the risks first.
Lifestyle
Vacuum pumps help treat erectile dysfunction in type 2 diabetes mellitus patients
In a trial of 66 men with type 2 diabetes whose erectile dysfunction did not respond well to 100 mg sildenafil alone, those given both Viagra and a vacuum erection device reported better penetration at one month (73% vs 47%) and better intercourse at three months (70% vs 47%).
Miscellaneous
Recycling Old Patents Helps Rural Villagers Power Sustainable Industries
Through an APEC project, Korean intellectual property experts helped villagers in Central Luzon, the Philippines adopt expired-patent technology to process ylang-ylang flowers into essential oil, after a single boiler in Anao town left only eight of eighteen villages able to make top-quality oil.
Miscellaneous
NIH awards $14.5 million to research groups studing newest DNA sequencying technique
The National Human Genome Research Institute awarded about $14.5 million to eight research teams over two to four years to develop cheaper, higher-quality DNA sequencing, much of it aimed at nanopores. They are the last grants from its Advanced DNA Sequencing Technology program.
Miscellaneous
Pennsylvania physicians applaud U.S. Surgeon General’s skin cancer declaration
Pennsylvania dermatologists and the state medical society backed Acting Surgeon General Boris Lushniak's July 29 declaration that skin cancer is a major public health problem, and pointed to the state's new tanning bed law. One cited a 59% higher melanoma risk from indoor tanning.
Miscellaneous
FDA approves Lumizyme to treat Pompe disease patients of all ages
The FDA approved Lumizyme (alglucosidase alfa) for infantile-onset Pompe disease in patients younger than 8 and is removing the drug's Risk Evaluation and Mitigation Strategy. Lumizyme had been limited since 2010 to late-onset patients aged 8 and older.
Drug
FDA approves Jardiance to treat type 2 diabetes
FDA approved Jardiance (empagliflozin) tablets as an addition to diet and exercise to improve blood sugar control in adults with type 2 diabetes. The SGLT2 inhibitor blocks glucose reabsorption in the kidney; seven trials in 4,480 patients showed better A1c levels than placebo.
5182 stories